The expression of CD44 per one granulocyte was unaffected in both IBD groups of our study, but the percentage of CD44+ granulocytes was elevated in Crohn’s disease compared to control and specifically in biologically treated patients with Crohn’s disease. This evidence concerns the gene CD44 and inflammatory bowel disease.